Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant.
The single-arm, prospective, open-label, non-randomized observational trial will enroll ~120 patients with persistent knee pain caused by injured or deteriorating meniscus cartilage, at up to 20 U.S. sites.
This trial joins the VENUS Study (Verification of the Effectiveness of the NUsurface System), which has been underway at 10 sites in the U.S. since 1Q15. Both studies are being conducted to support FDA regulatory approval.
Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant.
Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant.
The single-arm, prospective, open-label, non-randomized observational trial will enroll ~120 patients with persistent knee pain caused by injured or deteriorating meniscus cartilage, at up to 20 U.S. sites.
This trial joins the VENUS Study (Verification of the Effectiveness of the NUsurface System), which has been underway at 10 sites in the U.S. since 1Q15. Both studies are being conducted to support FDA regulatory approval.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
